Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Showing 1-25 of 141 citing articles:

Therapeutic targets and biomarkers of tumor immunotherapy: response versus non-response
Dongrui Wang, Xianlin Wu, Yingli Sun
Signal Transduction and Targeted Therapy (2022) Vol. 7, Iss. 1
Open Access | Times Cited: 287
Revealing the transcriptional heterogeneity of organ‐specific metastasis in human gastric cancer using single‐cell RNA Sequencing
Haiping Jiang, Dingyi Yu, Penghui Yang, et al.
Clinical and Translational Medicine (2022) Vol. 12, Iss. 2
Open Access | Times Cited: 144
Immune Checkpoint LAG3 and Its Ligand FGL1 in Cancer
An‐Ping Shi, Xiyang Tang, Yanlu Xiong, et al.
Frontiers in Immunology (2022) Vol. 12
Open Access | Times Cited: 124
Targets of Immune Escape Mechanisms in Cancer: Basis for Development and Evolution of Cancer Immune Checkpoint Inhibitors
Shovan Dutta, Anirban Ganguly, Kaushiki Chatterjee, et al.
Biology (2023) Vol. 12, Iss. 2, pp. 218-218
Open Access | Times Cited: 72
TIM-3 as a promising target for cancer immunotherapy in a wide range of tumors
Natalia Sauer, Natalia Janicka, Wojciech Szlasa, et al.
Cancer Immunology Immunotherapy (2023) Vol. 72, Iss. 11, pp. 3405-3425
Open Access | Times Cited: 63
Effects of Chemotherapy on the Immune System: Implications for Cancer Treatment and Patient Outcomes
Anirudh Sharma, Shivam Jasrotia, Ajay Kumar
Naunyn-Schmiedeberg s Archives of Pharmacology (2023) Vol. 397, Iss. 5, pp. 2551-2566
Closed Access | Times Cited: 42
Immune checkpoint molecules in natural killer cells as potential targets for cancer immunotherapy
Yuqing Cao, Xiaoyu Wang, Tianqiang Jin, et al.
Signal Transduction and Targeted Therapy (2020) Vol. 5, Iss. 1
Open Access | Times Cited: 120
Prognostic value of immune checkpoint molecules in breast cancer
Jun Fang, Feng Chen, Dong Liu, et al.
Bioscience Reports (2020) Vol. 40, Iss. 7
Open Access | Times Cited: 112
Highly Multiplexed Phenotyping of Immunoregulatory Proteins in the Tumor Microenvironment by CODEX Tissue Imaging
Darci J. Phillips, Christian M. Schürch, Michael S. Khodadoust, et al.
Frontiers in Immunology (2021) Vol. 12
Open Access | Times Cited: 91
Comprehensive of N1-Methyladenosine Modifications Patterns and Immunological Characteristics in Ovarian Cancer
Jinhui Liu, Can Chen, Yichun Wang, et al.
Frontiers in Immunology (2021) Vol. 12
Open Access | Times Cited: 62
Tumor microenvironment of human breast cancer, and feline mammary carcinoma as a potential study model
Catarina Nascimento, Fernando Ferreira
Biochimica et Biophysica Acta (BBA) - Reviews on Cancer (2021) Vol. 1876, Iss. 1, pp. 188587-188587
Open Access | Times Cited: 56
LAG-3 as a Potent Target for Novel Anticancer Therapies of a Wide Range of Tumors
Natalia Sauer, Wojciech Szlasa, Laura Jonderko, et al.
International Journal of Molecular Sciences (2022) Vol. 23, Iss. 17, pp. 9958-9958
Open Access | Times Cited: 52
Anti-PD-1/PD-L1 therapy for colorectal cancer: Clinical implications and future considerations
Xiang Chen, Lingjuan Chen, Xiaofei Peng, et al.
Translational Oncology (2023) Vol. 40, pp. 101851-101851
Open Access | Times Cited: 24
The therapeutic potential of PD-1/PD-L1 pathway on immune-related diseases: Based on the innate and adaptive immune components
Peng Zhang, Yuting Wang, Qianru Miao, et al.
Biomedicine & Pharmacotherapy (2023) Vol. 167, pp. 115569-115569
Open Access | Times Cited: 23
Mechanisms of Immune Escape and Resistance to Checkpoint Inhibitor Therapies in Mismatch Repair Deficient Metastatic Colorectal Cancers
Vito Amodio, Gianluca Mauri, Nicole M. Reilly, et al.
Cancers (2021) Vol. 13, Iss. 11, pp. 2638-2638
Open Access | Times Cited: 49
Expression of the immune checkpoint receptors PD-1, LAG3, and TIM3 in the immune context of stage II and III gastric cancer by using single and chromogenic multiplex immunohistochemistry
Yujun Park, An Na Seo, Jiwon Koh, et al.
OncoImmunology (2021) Vol. 10, Iss. 1
Open Access | Times Cited: 43
Cancer-associated inflammation: pathophysiology and clinical significance
Piotr Pęczek, Monika Gajda, Kacper Rutkowski, et al.
Journal of Cancer Research and Clinical Oncology (2022) Vol. 149, Iss. 6, pp. 2657-2672
Open Access | Times Cited: 33
Tim-3 Blockade Elicits Potent Anti-Multiple Myeloma Immunity of Natural Killer Cells
Wen Jiang, Fanglin Li, Yang Jiang, et al.
Frontiers in Oncology (2022) Vol. 12
Open Access | Times Cited: 30
The therapeutic potential of immunotherapy in the treatment of breast cancer: Rational strategies and recent progress
Hossein Javid, Fatemeh Attarian, Toktam Saadatmand, et al.
Journal of Cellular Biochemistry (2023) Vol. 124, Iss. 4, pp. 477-494
Closed Access | Times Cited: 17
Targeting the immune microenvironment for ovarian cancer therapy
Félix Blanc‐Durand, Lai Clemence Wei Xian, David S.P. Tan
Frontiers in Immunology (2023) Vol. 14
Open Access | Times Cited: 16
An exosome-derived lncRNA signature identified by machine learning associated with prognosis and biomarkers for immunotherapy in ovarian cancer
Yongjia Cui, Weixuan Zhang, Wenping Lü, et al.
Frontiers in Immunology (2024) Vol. 15
Open Access | Times Cited: 6
Immunotherapy in Testicular Germ Cell Tumors
Katarína Kaľavská, Silvia Schmidtova, Michal Chovanec, et al.
Frontiers in Oncology (2020) Vol. 10
Open Access | Times Cited: 43
Engineered Small Extracellular Vesicles as a FGL1/PD‐L1 Dual‐Targeting Delivery System for Alleviating Immune Rejection
Hsiang‐i Tsai, Yingyi Wu, Xiaoyan Liu, et al.
Advanced Science (2021) Vol. 9, Iss. 3
Open Access | Times Cited: 37
Comprehensive analysis of ferritin subunits expression and positive correlations with tumor-associated macrophages and T regulatory cells infiltration in most solid tumors
Zhangwei Hu, Lin Chen, Renqiang Ma, et al.
Aging (2021) Vol. 13, Iss. 8, pp. 11491-11506
Open Access | Times Cited: 36
Development and characterization of anti-galectin-9 antibodies that protect T cells from galectin-9-induced cell death
Ri‐Yao Yang, Linlin Sun, Ching-Fei Li, et al.
Journal of Biological Chemistry (2022) Vol. 298, Iss. 4, pp. 101821-101821
Open Access | Times Cited: 25
Page 1 - Next Page

Scroll to top